BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › mRNA and microRNA profile in colon cancer [mRNA data]

Dataset: mRNA and microRNA profile in colon cancer [mRNA data]

Compariosn of mRNA and miRNA profile in colon cancer mRNA was extracted from colon tissues for microarray analysis

Registered by ArrayExpress Uploader
View Dataset

Compariosn of mRNA and miRNA profile in colon cancer mRNA was extracted from colon tissues for microarray analysis

Species:
human

Samples:
65

Source:
E-GEOD-29621

Updated:
Dec.12, 2014

Registered:
Jul.11, 2014


Factors: (via ArrayExpress)
Sample T STAGE CORRESPONDING TO GSE17536 OS EVENT ADJUVANT CHEMO HISTOLOGIC GRADE SEX OVERALL SURVIVAL OS AJCC STAGING M STAGE 0 N STAGE DISEASE-FREE SURVIVAL TIME DFS DFS EVENT
GSM734175 3 GSM437176 dead Y MOD DIFF male 11.76 Stage 3 no; 1: metastasis): 0 2 8.21 recurrence
GSM734174 3 GSM437210 alive Y MOD DIFF female 54.54 Stage 3 no; 1: metastasis): 0 1 26.92 no recurrence
GSM734173 3 GSM437237 dead Y MOD DIFF male 15.28 Stage 4 no; 1: metastasis): 1 0 NA NA
GSM734172 3 GSM437158 alive Y MOD DIFF female 49.87 Stage 2 no; 1: metastasis): 0 0 36.75 no recurrence
GSM73417 4 GSM437129 alive Y MOD DIFF male 102.44 Stage 2 no; 1: metastasis): 0 0 64.86 no recurrence
GSM734170 3 GSM437148 alive N MOD DIFF female 52.14 Stage 2 no; 1: metastasis): 0 0 52.14 no recurrence
GSM734169 3 GSM437208 alive N MOD DIFF female 58.45 Stage 3 no; 1: metastasis): 0 1 58.45 no recurrence
GSM734168 3 GSM437185 alive Y WELL DIFF female 99.51 Stage 3 no; 1: metastasis): 0 1 99.51 no recurrence
GSM734167 2 GSM437114 alive N MOD DIFF male 3.64 Stage 1 no; 1: metastasis): 0 0 3.64 no recurrence
GSM734166 2 GSM437097 alive Y MOD DIFF male 59.53 Stage 1 no; 1: metastasis): 0 0 59.53 no recurrence
GSM734165 2 GSM437101 dead N MOD DIFF male 65.88 Stage 1 no; 1: metastasis): 0 0 65.88 no recurrence
GSM734164 2 GSM437115 alive N WELL DIFF male 36.59 Stage 1 no; 1: metastasis): 0 0 23.96 no recurrence
GSM734163 2 GSM437109 alive N MOD DIFF female 55.13 Stage 1 no; 1: metastasis): 0 0 55.13 no recurrence
GSM734162 2 GSM437106 alive N MOD DIFF female 67.82 Stage 1 no; 1: metastasis): 0 0 67.82 no recurrence
GSM73416 2 GSM437107 alive N WELL DIFF male 52.24 Stage 1 no; 1: metastasis): 0 0 52.24 no recurrence
GSM734160 3 GSM437173 dead N MOD DIFF female 27.15 Stage 2 no; 1: metastasis): 0 0 27.15 no recurrence
GSM734159 3 GSM437170 alive N MOD DIFF male 15.05 Stage 2 no; 1: metastasis): 0 0 15.05 no recurrence
GSM734158 3 GSM437169 alive Y MOD DIFF female 83.99 Stage 2 no; 1: metastasis): 0 0 22.38 recurrence
GSM734157 3 GSM437162 alive N MOD DIFF male 26.66 Stage 2 no; 1: metastasis): 0 0 26.66 no recurrence
GSM734156 3 GSM437161 alive N MOD DIFF male 35.9 Stage 2 no; 1: metastasis): 0 0 35.9 no recurrence
GSM734155 3 GSM437160 alive N MOD DIFF male 44.97 Stage 2 no; 1: metastasis): 0 0 44.97 no recurrence
GSM734154 3 GSM437159 alive N MOD DIFF male 25.24 Stage 2 no; 1: metastasis): 0 0 25.24 no recurrence
GSM734153 4 GSM437121 alive Y MOD DIFF female 120.62 Stage 2 no; 1: metastasis): 0 0 27.64 recurrence
GSM734152 3 GSM437155 alive Y MOD DIFF female 37.67 Stage 2 no; 1: metastasis): 0 0 17.95 no recurrence
GSM73415 3 GSM437152 alive Y MOD DIFF female 58.45 Stage 2 no; 1: metastasis): 0 0 46.71 no recurrence
GSM734150 3 GSM437150 alive N WELL DIFF male 59.96 Stage 2 no; 1: metastasis): 0 0 59.96 no recurrence
GSM734149 3 GSM437147 alive N POORLY DIFF female 34.09 Stage 2 no; 1: metastasis): 0 0 24.19 no recurrence
GSM734148 4 NA alive N POORLY DIFF female 61.57 Stage 2 no; 1: metastasis): X X 61.57 no recurrence
GSM734147 3 GSM437146 alive Y MOD DIFF male 63.25 Stage 2 no; 1: metastasis): 0 0 63.25 no recurrence
GSM734146 3 GSM437144 dead N MOD DIFF male 37.31 Stage 2 no; 1: metastasis): 0 0 37.31 no recurrence
GSM734145 3 GSM437118 alive N POORLY DIFF female 55.33 Stage 2 no; 1: metastasis): 0 0 55.33 no recurrence
GSM734144 3 GSM437128 alive Y MOD DIFF male 88.99 Stage 2 no; 1: metastasis): 0 0 88.99 no recurrence
GSM734143 3 GSM437126 dead N MOD DIFF female 52.5 Stage 2 no; 1: metastasis): 0 0 52.5 no recurrence
GSM734142 3 GSM437269 alive Y MOD DIFF male 22.35 Stage 4 no; 1: metastasis): 1 0 NA NA
GSM73414 4 GSM437264 dead N MOD DIFF female 9.96 Stage 4 no; 1: metastasis): 1 0 9.96 no recurrence
GSM734140 3 GSM437263 dead Y MOD DIFF male 14.56 Stage 4 no; 1: metastasis): 1 1 NA NA
GSM734139 3 GSM437262 dead N MOD DIFF male 15.25 Stage 4 no; 1: metastasis): 1 1 NA NA
GSM734138 3 GSM437255 alive Y MOD DIFF female 60.75 Stage 4 no; 1: metastasis): 1 1 55.19 no recurrence
GSM734137 3 GSM437259 alive Y MOD DIFF male 31.85 Stage 4 no; 1: metastasis): 1 1 NA NA
GSM734136 3 GSM437253 dead Y POORLY DIFF male 1.44 Stage 4 no; 1: metastasis): 1 1 NA NA
GSM734135 3 GSM437252 dead Y MOD DIFF female 34.02 Stage 4 no; 1: metastasis): 1 2 NA NA
GSM734134 3 GSM437231 dead Y MOD DIFF male 18.54 Stage 4 no; 1: metastasis): 1 1 NA NA
GSM734133 3 GSM437240 dead Y MOD DIFF male 28.89 Stage 4 no; 1: metastasis): 1 2 NA NA
GSM734132 3 GSM437238 alive Y MOD DIFF male 95.07 Stage 4 no; 1: metastasis): 1 1 82.61 no recurrence
GSM73413 3 GSM437236 dead Y MOD DIFF male 5.72 Stage 4 no; 1: metastasis): 1 1 NA NA
GSM734130 3 GSM437239 dead N MOD DIFF male 4.96 Stage 4 no; 1: metastasis): 1 1 NA NA
GSM734129 3 GSM437211 dead Y POORLY DIFF female 19.03 Stage 3 no; 1: metastasis): 0 1 8.58 recurrence
GSM734128 3 NA dead N MOD DIFF male 85.93 Stage 3 no; 1: metastasis): 0 1 79.46 recurrence
GSM734127 3 GSM437195 dead Y MOD DIFF male 59.07 Stage 3 no; 1: metastasis): 0 2 59.07 no recurrence
GSM734126 3 GSM437191 alive Y MOD DIFF female 85.61 Stage 3 no; 1: metastasis): 0 1 85.61 no recurrence
GSM734125 2 GSM437186 dead Y MOD DIFF male 20.44 Stage 3 no; 1: metastasis): 0 2 20.44 no recurrence
GSM734124 3 GSM437184 dead N POORLY DIFF male 6.11 Stage 3 no; 1: metastasis): 0 1 5.35 recurrence
GSM734123 3 GSM437196 dead Y POORLY DIFF male 47.8 Stage 3 no; 1: metastasis): 0 1 47.8 no recurrence
GSM734122 3 GSM437175 alive Y MOD DIFF male 105.17 Stage 3 no; 1: metastasis): 0 1 105.17 no recurrence
GSM73412 3 GSM437192 alive Y MOD DIFF male 78.87 Stage 3 no; 1: metastasis): 0 1 64.33 no recurrence
GSM734120 3 GSM437151 alive Y MOD DIFF male 47.86 Stage 2 no; 1: metastasis): 0 0 47.86 no recurrence
GSM734119 3 GSM437246 dead N MOD DIFF female 5.12 Stage 4 no; 1: metastasis): 1 2 NA NA
GSM734118 3 GSM437265 dead Y MOD DIFF male 8.94 Stage 4 no; 1: metastasis): 1 1 8.94 no recurrence
GSM734117 4 GSM437261 alive Y MOD DIFF male 42.27 Stage 4 no; 1: metastasis): 1 0 13.08 recurrence
GSM734116 3 GSM437205 dead Y MOD DIFF female 38.72 Stage 3 no; 1: metastasis): 0 1 38.72 no recurrence
GSM734115 3 GSM437266 alive Y POORLY DIFF female 32.67 Stage 4 no; 1: metastasis): 1 2 17.32 recurrence
GSM734114 3 GSM437209 alive Y POORLY DIFF male 59.34 Stage 3 no; 1: metastasis): 0 1 59.34 no recurrence
GSM734113 3 GSM437199 alive Y MOD DIFF male 74.07 Stage 3 no; 1: metastasis): 0 1 24.85 recurrence
GSM734112 3 GSM437206 dead N MOD DIFF female 54.9 Stage 3 no; 1: metastasis): 0 1 54.9 no recurrence
GSM734 3 GSM437213 alive Y POORLY DIFF male 52.86 Stage 3 no; 1: metastasis): 0 1 52.86 no recurrence

Tags

  • cancer
  • colon
  • colon cancer

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2026 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use